Sort   by:  
 Page size 
ProteomicsIdentification of ECM3 interactors by affinity purification followed by mass spectrometry analysis.
Identification of ECM3 interactors by affinity purification followed by mass spectrometry analysis.
ORGANISM(S): Mus musculus (Mouse) 
2022-11-03 | PXD017773 | Pride
Lungs Proteomics Affinity purification Ecm3 Interacting proteins 
UnknownEvidence for Regulation of ECM3 Expression by Methylation of Histone H3 Lysine 4 and Intergenic Transcription in Saccharomyces cerevisiae.
Not available
S-EPMC5015954 | biostudies-literature
UnknownNeoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.
Not available
S-EPMC3575489 | biostudies-literature
ProteomicsImpact of extracellular matrix on breast cancer progression: a biomechanical and shotgun proteomic analysis . ver LC-MSMS
It has become increasingly evident that the local microenvironment of breast cancer (BC) plays an important role in its development and progression. A major component of this microenvironment is the extracellular matrix (ECM) that impact tumor progression. We recently identified an ECM gene expressi...
ORGANISM(S): Homo sapiens (Human) 
2025-06-03 | PXD019037 | Pride
Proteomics nano lc-ms/ms breast cancer extracellular matrix 
UnknownExtracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment.
Not available
S-EPMC7072535 | biostudies-literature
UnknownInfrared Spectroscopic Imaging Visualizes a Prognostic Extracellular Matrix-Related Signature in Breast Cancer.
Not available
S-EPMC7096505 | biostudies-literature
TranscriptomicsExtracellular Matrix Regulates PD-1 on Tregs via IL-23 contributing to immune suppression in Breast Cancer
Background. High-grade breast cancer (HGBC) is an aggressive disease with a poor prognosis, highlighting the urgent need for new treatment strategies. The tumor microenvironment (TME), especially the extracellular matrix (ECM), plays a crucial role in tumor progression, therapy resistance, and immun...
ORGANISM(S): Mus musculus 
2025-09-10 | GSE282777 | GEO
UnknownA combination of extracellular matrix- and interferon-associated signatures identifies high-grade breast cancers with poor prognosis.
Not available
S-EPMC8096783 | biostudies-literature
UnknownECM-Induced IL-23 Drives Immune Suppression in Breast Cancer via Regulating PD-1 on Tregs.
Not available
S-EPMC12400771 | biostudies-literature
UnknownProteomic landscape of decellularized breast carcinomas identifies C-type lectin domain family 3 member A as a driver of cancer aggressiveness.
Not available
S-EPMC12144095 | biostudies-literature
Sort   by:  
 Page size